On November 11, 2021, Compugen Ltd. closed the transaction. The company announced a private placement of 2,332,815 shares at a price of $8.57333 per share for gross proceeds of $19,999,992.82395. The transaction included participation from returning investor, Bristol-Myers Squibb Company.